eMedevents
  • 141,605+ Medical Conferences
  • 273 Specialties
  • 10,681 Organizers
  • 153,448 Speakers
  • 156 Countries
  • 4,613 Cities
47,202+
CME Conference Registrations Sold
Home  >  Board Review Courses  >  Endocrinology and Rheumatology: The Most Practical and Useful Topics from Two Specialties 2020

Endocrinology and Rheumatology: The Most Practical and Useful Topics from Two Specialties 2020

Feb 03 - 07, 2020   |   Sarasota, Florida  United States of America
Specialties : Internal Medicine   |   General practice   |   Family Practice   |   Primary Care   |   Rheumatology   |   Endocrinology   |   Emergency Medicine
  Register Now

Endocrinology And Rheumatology: The Most Practical And Useful Topics From Two Specialties is organized by American Medical Seminars (AMS) and will be held from Feb 03 - 07, 2020 at The Westin Sarasota, Sarasota, Florida, United States of America. This Course has been approved for a maximum of 20 AMA PRA Category 1 Credits ™.

All AMS 2019-2020 CME conferences are Live, Half-day, Commercial-Support Free and are approved for AMA PRA Category 1 Credits™. Additional accreditation information available on our website.

All of our medical meetings are clinically useful evidence/case-based, guideline-driven, Primary Care content that is immediately applicable to your practice. All of our CME conferences, both live and recorded, can be found at www.AmericanMedicalSeminars.com.

AMS CME meetings are held in both Sarasota, FL and San Diego, CA, and are designed for Primary Care Practitioners in the specialties of Family Medicine, Internal Medicine, Emergency Medicine, and even Specialists who would like practical and clinically relevant reviews and updates in Primary Care Medicine.

Can’t attend our Live CME conferences? Check out our Self Study Travel CME courses on our website at www.AmericanMedicalSeminars.com.

Narrative Description:
Following this course, the participant should be able to appraise the epidemiology and presenting complaints of the commonly seen disorders within the specialities of Endocrinology and Rheumatology; apply a practical approach to the use of laboratory studies and physical exam for developing a differential or diagnosis; determine the various treatment options available and choose appropriate specialty referral or follow-up. This activity is expected to result in improved competence in making an appropriate diagnosis and providing effective treatment and referral or follow-up care with the overall goal of improving patient outcomes.

When indicated in the specific objectives, emphasis will be on aligning physician behavior with current guidelines and evidence-based medicine with a focus on diagnosis, treatment and when to refer.  Since the specialties of Endocrinology and Rheumatology impact patient populations of all demographics, there is a need for providers to be up-to-date on common Endocrine and Rheumatologic diseases; therefore, this course was designed as an update for all practitioners at the level of a practicing physician.

Specific Objectives:
DAY 1 
Adrenal Insufficiency- Primary and Secondary.

Upon completion of this session, using evidence-based medicine and clinical practice guidelines, to include Endocrine Society Guidelines, the participant should be able to: COMP
• Apply principles learned to evaluate the diagnostic tests used to confirm the diagnosis or primary or secondary adrenal insufficiency.  
• Employ therapeutic options for patients including pregnant patients with primary or secondary adrenal insufficiency.

Cushing’s Syndrome and other Functional Disorders of the Adrenal. 
Upon completion of this session, using evidence-based medicine and clinical practice guidelines, to include Endocrine Society Practice guidelines, the participant should be able to: COMP
• Outline the etiology of Cushing’s syndrome.
• Evaluate a patient with an adrenal tumor.  
• Evaluate a patient for suspected hyperaldosteronism.
• To employ strategies to appropriately diagnosis and manage patients with pheochromocytoma.

Approach to the Patient with Rheumatic Diseases.
Upon completion of this session, the participant should be able to: GL, EBM, COMP  
• Demonstrate the importance of the history and physical exam including patterns of joints involvement and extra-articular findings in evaluating patients with rheumatic diseases.
• Distinguish inflammatory (i.e. rheumatoid arthritis) and structural arthritis (i.e. osteoarthritis).
• Differentiate patterns of articular involvement associated with different arthritides.
• Utilize laboratory and radiological studies in the evaluation of patients with rheumatic diseases.

Rheumatoid Arthritis.
Upon completion of this session, the participant should be able to:GL, COMP  
• Demonstrate the role of genetics, environmental factors, immune cells, and proinflammatory cytokines in the pathogenesis of rheumatoid arthritis.
• Illustrate the clinical features, extra-articular manifestations, and complications of rheumatoid arthritis.
• Utilize and compare various methods of measuring disease activity in rheumatoid arthritis.
• Compare and contrast the mechanisms of action of current and emerging therapies for RA and prescribe treatment for patients with rheumatoid arthritis according to ACR guidelines.

DAY 2 
Thyroid Case Studies.

Upon completion of this session, using evidence-based medicine and clinical practice guidelines, to include the American Thyroid Association Guidelines, the participant should be able to: COMP  
• Appreciate the role of a diagnostic thyroid scan or ultrasound.
• Evaluate a patient for hyperthyroidism.
• Prescribe therapeutic options for patients diagnosed with hypothyroidism.

Disorders of Calcium Metabolism.
Upon completion of this session, using evidence-based medicine from the JCEM, Annual of IM and others, the participant should be able to: COMP  
• Outline the causes of hypercalcemia.
• Recommend diagnostic testing for hyperparathyroidism.
• Recognize secondary hyperparathyroidism.
• Determine appropriate need for surgical intervention using clinical practice guidelines for asymptomatic hyperparathyroidism.

Systemic Lupus Erythematosus.
Upon completion of this session, the participant should be able to: GL, EBM, COMP  
• Describe the varied clinical presentations and manifestations in the course of systemic lupus erythematosus.  
• Order and interpret laboratory testing used in the diagnosis of systemic lupus erythematosus in accordance with ACR Guidelines.  
• Monitor and employ treatment options for patients with systemic lupus erythematosus according to EULAR recommendations and evidence-based results from clinical studies.

Scleroderma and Raynaud's Disease.
Upon completion of this session, the participant should be able to: GL, COMP  
• Specify the clinical manifestations of scleroderma.  
• Apply the ACR/EULAR classification criteria for systemic sclerosis.
• Utilize treatment available for symptomatic manifestations as per the current EULAR recommendations.  
• Apply the diagnostic work-up and treatment of Raynaud’s Phenomenon.

DAY 3
Male Hypogonadism.

Upon completion of this session, using evidence-based medicine from the JCEM, NEJM and others, the participant should be able to: COMP  
• Outline the classic causes of male hypogonadism.
• Appreciate the entity of adult onset hypogonadism.
• Describe the risks and benefits of testosterone use and apply toward decision making when reviewing treatment options.

Polycystic Ovary Syndrome.
Upon completion of this session, using evidence-based medicine and clinical practice guidelines, to include Rotterdam Guidelines, the participant should be able to: COMP  
• Recognize the distinguishing features of PCOS.
• Prescribe appropriate laboratory tests to evaluate women with hirsutism.
• Describe the non-reproductive aspects of PCOS.

Cardiovascular Complications of Rheumatic Diseases (BRECHER).
Upon completion of this session, the participant should be able to: GL, EBM, COMP  
• Recognize the increased risk for cardiovascular diseases in specific rheumatic disorders.
• Identify types of patients with rheumatic disorders which have high risk for cardiovascular disease.

Osteoporosis (BRECHER).
Upon completion of this session, the participant should be able to: GL, EBM, COMP  
• Detect patients who are at risk for osteoporosis.
• Recognize the need for bone density testing as recommended by the International Society of Clinical Densitomethy and the National Osteoporosis Foundation guidelines.
• Differentiate the nonpharmacologic and pharmacologic treatments for osteoporosis as recommended by the National Osteoporosis Foundation guidelines.   

DAY 4     
Spondyloarthropathies.

Upon completion of this session, the participant should be able to: EBM, COMP  
• Distinguish the clinical features of the different spondyloarthropathies to improve diagnostic accuracy.
• Utilize clinical features, laboratory studies, and radiological studies to make a diagnosis of axial spondyloarthropathy.
• Prescribe pharmacologic agents according to ACR and EULAR recommendations and evidence-based results from clinical trials for patients with spondyloarthropathies.

Rheumatologic Procedures.
Upon completion of this session, the participant should be able to: GL, COMP  
• Use techniques for appropriate indications for intra-articular and soft tissue injections in rheumatology.
• Employ appropriate pharmacologic and non-pharmacologic therapies including injections for painful joints as per the ACR recommendations and the various sited rheumatologic and META analysis studies.

Idiopathic Inflammatory Myopathies (BRECHER).
Upon completion of this session, the participant should be able to: GL, EBM, COMP  
• Distinguish the different inflammatory myopathies as outlined in the 2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria.
• Utilize clinical features and appropriate testing to make the diagnosis of inflammatory myopathies.
• Illustrate the pharmacologic agents used according to ACR and EULAR recommendations based upon evidence-based results from clinical trials for patients with idiopathic inflammatory myopathy.

Crystal Arthropathies (BRECHER).
Upon completion of this session, the participant should be able to: GL, EBM, COMP  
• Illustrate the presenting signs and symptoms of crystal induced arthritis using evidence-based medicine.
• Order appropriate testing to confirm the diagnosis of crystal induced arthritis.
• Apply American College of Rheumatology guidelines in the treatment of crystal arthropathies including gout and pseudogout.   

DAY 5 
Septic Arthritis.

Upon completion of this session, the participant should be able to: GL, EBM, COMP 
• Determine the risk factors associated with septic arthritis.
• Utilize the British Society of Rheumatology Guidelines for management of the hot swollen joint in adults to differentiate septic arthritis from other causes of acute monoarticular arthritis.  
• Utilize epidemiological and clinical clues to determine bacterial etiology in patients with septic arthritis.

Lyme Disease and Other Topics in Rheumatology.
Upon completion of this session, the participant should be able to: EBM, GL, COMP  
• Apply CDC and Infectious Diseases Society of America Guidelines for the diagnosis, treatment, and prevention of Lyme disease.
• Evaluate skin rashes as manifestations of systemic diseases.
• Using the Guidelines of the Bone Research Society of the United Kingdom to prescribe appropriate therapy for patients with Paget’s disease of the Bone.

Vasculitis. (BRECHER).
Upon completion of these sessions, the participant should be able to: 
• Recognize the various types of vasculitis as defined by the revised International Chapel Hill si
• Demonstrate an understanding of the treatments for polymyalgia rheumatica and giant cell arteritis as well as their potential treatment toxicities using evidence – based medicine

Approach to Musculoskeletal Pain. (BRECHER).
Upon completion of these sessions, the participant should be able to: 
• Assess a patient presenting with musculoskeletal complaints.
• Employ appropriate pattern recognition to elucidate the underlying cause of musculoskeletal complaints.
• Utilize clinical history, physical exam, and appropriate laboratory testing to support a clinical diagnosis related to musculoskeletal complaints using evidence -based medicine.

Speaking

Linda S. Brecher
Linda S. Brecher

Rheumatology

Stephen J. Winters
Stephen J. Winters

Endocrinology, Metabolism and Diabetes

Lawrence H. Brent
Lawrence H. Brent

Rheumatology

Course Details

Session url : Click here
Social Media Info :      

Registration Desk

Contact No. : 941-388-1766
Email:
mail@ams4cme.com

Registration

Registration Type Last Date Price
Physician/Resident Early Fee 02 Jan,2020 USD 899.00
Non Physician/Resident Early Fee 02 Jan,2020 USD 799.00
  • Drive Walk Transit Bicycle

Venue Address

The Westin Sarasota
100 Marina View Drive
Sarasota, Florida, United States of America

Official Hotel

The Westin Sarasota,

100 Marina View Drive,

Sarasota, Florida, United States of America 34236,

+1 941-217-4777

Plan Your Travel

 
 
 
 

Please Rate this Course

 0.0
 0.0
 0.0
 0.0
 0.0

Reviews Given by People

No Reviews available. Be the first to write a review.

Hotels Near Venue

Treasure Island Beach Resort
33.13 miles from venue
Price : USD 219.00 Per Night
The Vinoy® Renaissance St. Petersburg Resort & Golf Club
31.06 miles from venue
Price : USD 229.00 Per Night
TradeWinds Island Grand
29.88 miles from venue
Price : USD 239.20 Per Night
The Hotel Zamora
28.74 miles from venue
Price : USD 179.55 Per Night
Close

Session Details

Session Topic Start Time End Time Location Description Speakers
Close

Workshop Details

Title Start Time End Time Workshop Fee

Subscribe to our Newsletter

x

Subscribe to our newsletter and receive updates on medical conferences, board review courses and news